Company / PP&E per Share
Arcadia Biosciences, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $1.27
FY2021-FY2025
Trend
-81.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has declined for 3 consecutive years, from $1.27 in FY2022 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -57.2%.
Declined from $0.62 to $0.01 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -83.3%
- 5-Year CAGR
- -57.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 81.6% year-over-year.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -81.6% |
| FY2024 | $0.03 | -94.9% |
| FY2023 | $0.62 | -50.9% |
| FY2022 | $1.27 | +645.3% |
| FY2021 | $0.17 | -58.4% |
| FY2020 | $0.41 | +8.6% |
| FY2019 | $0.38 | +103.6% |
| FY2018 | $0.19 | +37.7% |
| FY2017 | $0.13 | +1069.1% |
| FY2016 | $0.01 | -95.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026